GETTING STARTED GUIDE
How to start GLP-1 treatment with the full picture.
Learn what happens in an online visit, what a licensed provider decides, what the plan costs and where to find reliable guidance before you begin.
The questionnaire takes about 5–10 minutes. A provider decides whether a prescription is appropriate.
THE PROCESS
What happens after you begin?
The sequence matters: you choose and pay for a plan, then a licensed provider reviews your completed assessment.
- 01 / 04
Share your health history
Complete the online questionnaire with your medical history, current medications and care goals.
About 5–10 minutes - 02 / 04
Choose a plan and pay
Review the treatment and billing options. Checkout happens before a licensed provider reviews your assessment.
Full charge shown before payment - 03 / 04
Get an individual decision
A licensed provider decides whether treatment is appropriate and may request more information. A prescription is not assured.
Typically 12–24 hours after completion - 04 / 04
Receive care, if prescribed
A state-licensed 503A pharmacy prepares the prescription. It ships free overnight once compounded.
Pharmacy preparation and support
Provider review typically takes 12–24 hours after a completed assessment. Requests for more information and pharmacy preparation can change the overall timing.
CLEAR PRICING
Know the charge before you choose.
The annual plan has the lowest monthly equivalent, but the full annual amount is charged at checkout. Monthly, quarterly and six-month plans are also available.
Compounded semaglutide
ANNUAL PLAN
$1,188charged once yearly
12-month commitment
Equivalent to $99 per month when divided by 12. This is not a monthly charge.
Monthly plan$175 charged each month
Compounded tirzepatide
ANNUAL PLAN
$1,500charged once yearly
12-month commitment
Equivalent to $125 per month when divided by 12. This is not a monthly charge.
Monthly plan$235 charged each month
EXPLORE AT YOUR PACE
Find the answer you need next.
Choose a topic to explore before deciding whether to start an online visit.
ELIGIBILITY & SAFETY
The provider decision is personal.
Eligibility is determined from your individual health history, current medications and treatment goals. A provider may ask for more information or evaluation. There is no prescription without a clinical decision.
Tell your provider about your medical conditions, all medications and any personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
Read important safety informationWHEN YOU ARE READY
Take the first step with clear expectations.
Complete the questionnaire, review the full plan charge and get an individual provider decision.
Medical information: This page is educational, not medical advice. Do not start, stop or change medication based on website content alone. Discuss your full history with a licensed provider.
Compounded medications: Compounded semaglutide and tirzepatide are prepared per individual prescription by state-licensed 503A pharmacies. They are not FDA-approved. FDA does not review them for safety, effectiveness or quality before marketing.
Risks and outcomes: Side effects can include nausea, vomiting, diarrhea and constipation. Serious risks include pancreatitis, gallbladder problems and kidney injury. Branded semaglutide and tirzepatide carry boxed warnings about thyroid C-cell tumors observed in rodents; risk in humans is unknown. Individual results vary.